TP53 and neoplasm: Studies using human cells both in vitro and in immunodeficient mice demonstrated that SMYD2 represses the activity of tumor suppressers p53 (apoptosis) and RB1 (cell-cycle arrest) via mono-methylation at p53:K370 and RB1:K860 and K810 [8,10,11].